
The global Blood Specimen Container market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The “Blood Specimen Container Industry Forecast” looks at past sales and reviews total world Blood Specimen Container sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Specimen Container sales for 2025 through 2031. With Blood Specimen Container sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Specimen Container industry.
This Insight Report provides a comprehensive analysis of the global Blood Specimen Container landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Specimen Container portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Specimen Container market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Specimen Container and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Specimen Container.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Specimen Container market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polypropylene
High Density Poly Ethylene
PVC
Others
Segmentation by Application:
Cups
Bottles
Jars
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Cardinal Health
Sterimed
BD
Thermo Fisher Scientific
Envases Group
Kartell P.I.
SARSTEDT AG & Co. KG
FL MEDICAL s.r.l.
Vernacare
VITLAB GmbH
Wanpow Plastic Industries Sdn Bhd.
Dynarex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Specimen Container market?
What factors are driving Blood Specimen Container market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Specimen Container market opportunities vary by end market size?
How does Blood Specimen Container break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Specimen Container Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Blood Specimen Container by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Blood Specimen Container by Country/Region, 2020, 2024 & 2031
2.2 Blood Specimen Container Segment by Type
2.2.1 Polypropylene
2.2.2 High Density Poly Ethylene
2.2.3 PVC
2.2.4 Others
2.3 Blood Specimen Container Sales by Type
2.3.1 Global Blood Specimen Container Sales Market Share by Type (2020-2025)
2.3.2 Global Blood Specimen Container Revenue and Market Share by Type (2020-2025)
2.3.3 Global Blood Specimen Container Sale Price by Type (2020-2025)
2.4 Blood Specimen Container Segment by Application
2.4.1 Cups
2.4.2 Bottles
2.4.3 Jars
2.4.4 Others
2.5 Blood Specimen Container Sales by Application
2.5.1 Global Blood Specimen Container Sale Market Share by Application (2020-2025)
2.5.2 Global Blood Specimen Container Revenue and Market Share by Application (2020-2025)
2.5.3 Global Blood Specimen Container Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Blood Specimen Container Breakdown Data by Company
3.1.1 Global Blood Specimen Container Annual Sales by Company (2020-2025)
3.1.2 Global Blood Specimen Container Sales Market Share by Company (2020-2025)
3.2 Global Blood Specimen Container Annual Revenue by Company (2020-2025)
3.2.1 Global Blood Specimen Container Revenue by Company (2020-2025)
3.2.2 Global Blood Specimen Container Revenue Market Share by Company (2020-2025)
3.3 Global Blood Specimen Container Sale Price by Company
3.4 Key Manufacturers Blood Specimen Container Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Specimen Container Product Location Distribution
3.4.2 Players Blood Specimen Container Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Blood Specimen Container by Geographic Region
4.1 World Historic Blood Specimen Container Market Size by Geographic Region (2020-2025)
4.1.1 Global Blood Specimen Container Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Blood Specimen Container Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Blood Specimen Container Market Size by Country/Region (2020-2025)
4.2.1 Global Blood Specimen Container Annual Sales by Country/Region (2020-2025)
4.2.2 Global Blood Specimen Container Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blood Specimen Container Sales Growth
4.4 APAC Blood Specimen Container Sales Growth
4.5 Europe Blood Specimen Container Sales Growth
4.6 Middle East & Africa Blood Specimen Container Sales Growth
5 Americas
5.1 Americas Blood Specimen Container Sales by Country
5.1.1 Americas Blood Specimen Container Sales by Country (2020-2025)
5.1.2 Americas Blood Specimen Container Revenue by Country (2020-2025)
5.2 Americas Blood Specimen Container Sales by Type (2020-2025)
5.3 Americas Blood Specimen Container Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Specimen Container Sales by Region
6.1.1 APAC Blood Specimen Container Sales by Region (2020-2025)
6.1.2 APAC Blood Specimen Container Revenue by Region (2020-2025)
6.2 APAC Blood Specimen Container Sales by Type (2020-2025)
6.3 APAC Blood Specimen Container Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blood Specimen Container by Country
7.1.1 Europe Blood Specimen Container Sales by Country (2020-2025)
7.1.2 Europe Blood Specimen Container Revenue by Country (2020-2025)
7.2 Europe Blood Specimen Container Sales by Type (2020-2025)
7.3 Europe Blood Specimen Container Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Specimen Container by Country
8.1.1 Middle East & Africa Blood Specimen Container Sales by Country (2020-2025)
8.1.2 Middle East & Africa Blood Specimen Container Revenue by Country (2020-2025)
8.2 Middle East & Africa Blood Specimen Container Sales by Type (2020-2025)
8.3 Middle East & Africa Blood Specimen Container Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Specimen Container
10.3 Manufacturing Process Analysis of Blood Specimen Container
10.4 Industry Chain Structure of Blood Specimen Container
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Specimen Container Distributors
11.3 Blood Specimen Container Customer
12 World Forecast Review for Blood Specimen Container by Geographic Region
12.1 Global Blood Specimen Container Market Size Forecast by Region
12.1.1 Global Blood Specimen Container Forecast by Region (2026-2031)
12.1.2 Global Blood Specimen Container Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Blood Specimen Container Forecast by Type (2026-2031)
12.7 Global Blood Specimen Container Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Cardinal Health
13.1.1 Cardinal Health Company Information
13.1.2 Cardinal Health Blood Specimen Container Product Portfolios and Specifications
13.1.3 Cardinal Health Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Main Business Overview
13.1.5 Cardinal Health Latest Developments
13.2 Sterimed
13.2.1 Sterimed Company Information
13.2.2 Sterimed Blood Specimen Container Product Portfolios and Specifications
13.2.3 Sterimed Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sterimed Main Business Overview
13.2.5 Sterimed Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Blood Specimen Container Product Portfolios and Specifications
13.3.3 BD Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Blood Specimen Container Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Envases Group
13.5.1 Envases Group Company Information
13.5.2 Envases Group Blood Specimen Container Product Portfolios and Specifications
13.5.3 Envases Group Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Envases Group Main Business Overview
13.5.5 Envases Group Latest Developments
13.6 Kartell P.I.
13.6.1 Kartell P.I. Company Information
13.6.2 Kartell P.I. Blood Specimen Container Product Portfolios and Specifications
13.6.3 Kartell P.I. Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kartell P.I. Main Business Overview
13.6.5 Kartell P.I. Latest Developments
13.7 SARSTEDT AG & Co. KG
13.7.1 SARSTEDT AG & Co. KG Company Information
13.7.2 SARSTEDT AG & Co. KG Blood Specimen Container Product Portfolios and Specifications
13.7.3 SARSTEDT AG & Co. KG Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 SARSTEDT AG & Co. KG Main Business Overview
13.7.5 SARSTEDT AG & Co. KG Latest Developments
13.8 FL MEDICAL s.r.l.
13.8.1 FL MEDICAL s.r.l. Company Information
13.8.2 FL MEDICAL s.r.l. Blood Specimen Container Product Portfolios and Specifications
13.8.3 FL MEDICAL s.r.l. Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 FL MEDICAL s.r.l. Main Business Overview
13.8.5 FL MEDICAL s.r.l. Latest Developments
13.9 Vernacare
13.9.1 Vernacare Company Information
13.9.2 Vernacare Blood Specimen Container Product Portfolios and Specifications
13.9.3 Vernacare Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Vernacare Main Business Overview
13.9.5 Vernacare Latest Developments
13.10 VITLAB GmbH
13.10.1 VITLAB GmbH Company Information
13.10.2 VITLAB GmbH Blood Specimen Container Product Portfolios and Specifications
13.10.3 VITLAB GmbH Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 VITLAB GmbH Main Business Overview
13.10.5 VITLAB GmbH Latest Developments
13.11 Wanpow Plastic Industries Sdn Bhd.
13.11.1 Wanpow Plastic Industries Sdn Bhd. Company Information
13.11.2 Wanpow Plastic Industries Sdn Bhd. Blood Specimen Container Product Portfolios and Specifications
13.11.3 Wanpow Plastic Industries Sdn Bhd. Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Wanpow Plastic Industries Sdn Bhd. Main Business Overview
13.11.5 Wanpow Plastic Industries Sdn Bhd. Latest Developments
13.12 Dynarex
13.12.1 Dynarex Company Information
13.12.2 Dynarex Blood Specimen Container Product Portfolios and Specifications
13.12.3 Dynarex Blood Specimen Container Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Dynarex Main Business Overview
13.12.5 Dynarex Latest Developments
14 Research Findings and Conclusion
*If Applicable.
